The growth of Viagra and its influence on the medicinal landscape presents a complex question for shareholders. While the first sales statistics were astounding, the patent has ended, leading to a flood of off-brand https://adamtjmr170380.blogdun.com/42082571/the-blue-pill-and-pharma-a-speculative-investment